PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 22, 20240 citationsOpen Access

Figure S8 from Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects

View Full Paper
AEAlexandria P. EikenASAudrey L. SmithSSSydney A. Skupa

Key Points

Key points are not available for this paper at this time.

Abstract

Figure S8 shows the studies with SpiD3AP in CLL.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Eiken et al. (2024) studied this question.

synapsesocial.com/papers/68e68fb4b6db643587616b0ehttps://doi.org/10.1158/2767-9764.25880258.v1
Ask AI
Helpful
Bookmark
Share
View Full Paper